Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

NCT04276688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Novel Coronavirus Infection

Interventions

DRUG: Lopinavir/ritonavir
DRUG: Ribavirin
DRUG: Interferon Beta-1B

Sponsor

The University of Hong Kong

Collaborators

[object Object]